N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer.

Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Qin X

Open source

DOI
10.3892/ijo.2022.5304
Published
2022 Feb
Container
International journal of oncology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ijo.2022.5304,
  title = {N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer.},
  author = {Pan S and Deng Y and Fu J and Zhang Y and Zhang Z and Qin X},
  year = {2022},
  journal = {International journal of oncology},
  doi = {10.3892/ijo.2022.5304},
  url = {https://doi.org/10.3892/ijo.2022.5304}
}

RIS

TY  - JOUR
TI  - N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer.
AU  - Pan S
AU  - Deng Y
AU  - Fu J
AU  - Zhang Y
AU  - Zhang Z
AU  - Qin X
PY  - 2022
JO  - International journal of oncology
DO  - 10.3892/ijo.2022.5304
UR  - https://doi.org/10.3892/ijo.2022.5304
ER  - 

APA

S, P., Y, D., J, F., Y, Z., Z, Z., & X, Q. (2022). N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer.. International journal of oncology. https://doi.org/10.3892/ijo.2022.5304

Source records